Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Comtan (Entacapone) is used for the treatment of Parkinson’s disease. This is used with other medications like carbidopa and levodopa to treat such a condition. Parkinson’s disease is a progressive nervous system disorder that affects the movement. A symptom begins slowly, sometimes starting with a barely noticeable tremor in just one hand. Tremors are corporate but the disorder also commonly causes the slowing of movement.
Comtan (Entacapone) is an enzyme that usually breaks down excess dopamine in the brain. As Parkinson’s disease patients have a reduction in dopamine, blocking the action of this enzyme can result in dopamine levels to increase. This effect lets the levodopa to last longer in the system so that it does not wear off before the next prescription.
Comtan (Entacapone) is a catechol-O-methyltransferase (COMT) inhibitor. It is a member of the class of nitrocatechols. This is available as tablets containing 200mg of Entacapone. In 1999, the Food and Drug Administration (FDA) approved this treatment.
The dosage is based on your medical condition and response to the treatment. You may take this drug with or without food. Take it by mouth with a full glass of water. It is usually prescribed carbidopa or levodopa up to 8 times daily. Follow all the prescription of your doctor very carefully. Take it regularly or at the same time each day. To avoid some complications, do not take twice the prescribed dosage.